Statistical Characterization of Succinoylated Dextrin Degradation Behavior in Human α-Amylase

REFERENCES

• Duncan , R. 2011 . Polymer therapeutics as nanomedicines: new perspectives . Curr. Opin. Biotechnol. , 22 ( 4 ) : 492 – 501 .
   PubMed Web of Science ®Google Scholar
• Duncan , R. 2003 . The dawning era of polymer therapeutics . Nat. Rev. Drug Discov. , 2 ( 5 ) : 347 – 360 .
   PubMed Web of Science ®Google Scholar
• Guo , A. , Wolfson , M. and Holt , R. 2002 . Early quality of life benefits of icodextrin in peritoneal dialysis . Kidney Int. , 62 : S72 – S79 .
   Google Scholar
• Davies , S. J. 2006 . Exploring new evidence of the clinical benefits of icodextrin solutions . Nephrol. Dialysis Transplant. , 21 : 47 – 50 .
   Web of Science ®Google Scholar
• Federal Drug Agency . 2010 . FDA approved drug products-icodextrin . [06/06/2010]; Available from: http://www.accessdata.fda.gov/scripts/cder/ drugsatfda/index.cfm?fusea ction=Search.DrugDetails&#totable
   Google Scholar
• Hermanson , G. T. 2008 . Bioconjugate Techniques. 2nd ed. , Rockford , MI : Elsevier Publishing .
   Google Scholar
• Hreczuk-Hirst , D. , Chicco , D. , German , L. and Duncan , R. 2001 . Dextrins as potential carriers for drug targeting: tailored rates of dextrin degradation by introduction of pendant groups . Int. J. Pharmaceutics. , 230 ( 1–2 ) : 57 – 66 .
   PubMed Web of Science ®Google Scholar
• Ferguson , E. L. and Duncan , R. 2009 . Dextrin-phospholipase A2: synthesis and evaluation as a bioresponsive anticancer conjugate . Biomacromolecules. , 10 ( 6 ) : 1358 – 1364 .
   PubMed Web of Science ®Google Scholar
• Hardwicke , J. , Ferguson , E. , Moseley , R. , Stephens , P. , Thomas , D. and Duncan , R. 2008 . Dextrin-rhEGF conjugates as bioresponsive nanomedicines for wound repair . J. Controlled Release. , 130 ( 3 ) : 275 – 283 .
   PubMed Web of Science ®Google Scholar
• Duncan , R. , Gilbert , H. , Carbajo , R. and Vicent , M. 2008 . Polymer masked-unmasked protein therapy. 1. Bioresponsive dextrin-trypsin and -melanocyte stimulating hormone conjugates designed for alpha-amylase activation . Biomacromolecules. , 9 ( 4 ) : 1146 – 1154 .
   PubMed Web of Science ®Google Scholar
• Hreczuk-Hirst , D. , German , L. and Duncan , R. 2001 . Dextrins as carriers for drug targeting: reproducible succinoylation as a means to introduce pendant groups . J. Bioactive Compatible Polymers , 16 ( 5 ) : 353 – 365 .
   Web of Science ®Google Scholar
• Treetharnmathurot , B. , Dieudonne , L. , Ferguson , E. L. , Schmaljohann , D. , Duncan , R. and Wiwattanapatapee , R. 2009 . Dextrin-trypsin and ST-HPMA-trypsin conjugates: enzyme activity, autolysis and thermal stability . Int. J. Pharmaceutics , 373 ( 1–2 ) : 68 – 76 .
   PubMed Web of Science ®Google Scholar
• Gaspar , R. and Duncan , R. 2009 . Polymeric carriers: preclinical safety and the regulatory implications for design and development of polymer therapeutics . Advanced Drug Delivery Rev. , 61 ( 13 ) : 1220 – 1231 .
   PubMed Web of Science ®Google Scholar
• Lin , C-C. and Metters , A. T. 2006 . Hydrogels in controlled release formulations: network design and mathematical modeling . Advanced Drug Delivery Rev. , 58 ( 12–13 ) : 1379 – 1408 .
   PubMed Web of Science ®Google Scholar
• Hardwicke , J. , Moseley , R. , Stephens , P. , Harding , K. , Duncan , R. and Thomas , D. W. 2010 . Bioresponsive dextrin-rhEGF conjugates: in vitro evaluation in models relevant to its proposed use as a treatment for chronic wounds . Molec. Pharmaceutics. , 7 ( 3 ) : 699 – 707 .
   PubMed Web of Science ®Google Scholar
• Hardwicke , J. T. , Hart , J. , Bell , A. , Duncan , R. , Thomas , D. W. and Moseley , R. 2011 . The effect of dextrin–rhEGF on the healing of full-thickness, excisional wounds in the (db/db) diabetic mouse . J. Controlled Release. , 152 ( 3 ) : 411 – 417 .
   PubMed Web of Science ®Google Scholar
• Azzopardi , E. A. , Ferguson , E. L. and Thomas , D. W. 2013 . A new class of nanoantibiotics directed at multidrug resistant infection- ex vivo kinetics and targeting potential. BP 15. Society of Academic Research Surgery; London . Br. J. Surg. , : 74
   Web of Science ®Google Scholar
• Azzopardi , E. A. , Ferguson , E. L. and Thomas , D. W. 2013 . The enhanced permeability retention effect: a new paradigm for drug targeting in infection . J. Antimicrob. Chemother. , 68 ( 2 ) : 257 – 274 .
   PubMed Web of Science ®Google Scholar
• Burkart , J. 2004 . Metabolic consequences of pentoneal dialysis . Seminars in Dialysis , 6 : 498 – 504 .
   Web of Science ®Google Scholar